Search results for: 'Software License Management Market'

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At AU...

This market engineering research service has been developed to address the advanced wound management in Taiwan. This research service presents the key findings of market. It provides insights and forecast of market size, overview, and strategic recommendations. This research service also discusses market trends, market drivers, and market restraint...

This research service presents the key findings of end users research conducted in 2007 for the Australian Wound Care Management Market. It provides insights of end-users preferred products and brands for different types of wound care. End -users' perceived product benefits and satisfaction towards products used were included. It also discussed the...

A market outlook of the Cardiac Rhythm Management Devices covering China, Hong Kong, South Korea and Malaysia. This study includes the market drivers, restraints and forecasting for the pacemaker, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices and CRM leads. The forecast period of the study is from 2...

In this first Customer Experience Management report for Malaysias Medical Insurance industry, Frost & Sullivan explores the relationship of the experiences provided by medical insurance companies for its customers. We look at the critical factors that influence customer behaviours throughout the three phases (pre-purchase, purchase and post-purcha...

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

19 Apr 2017  |  Asia Pacific  |  Market Research

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

Infographics

×

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...